Defining Demographic-specific Coronary Artery Calcium Percentiles in the Population Aged 75: The ARIC Study and MESA

Frances M Wang1, Miguel Cainzos-Achirica1,2, Shoshana H Ballew1

  • 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (F.M.W., M.C.-A., S.H.B., J.C., W.S.P., M.J.B., K.M.).

PubMed

Insights

Current guidelines for coronary artery calcium (CAC) scores lack data for adults over 75. This study establishes new demographic-specific CAC percentiles for this age group, finding most older adults exceed the high-risk threshold.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Preventive Cardiology

Background:

  • Current clinical guidelines for atherosclerotic cardiovascular disease (ASCVD) preventive therapy rely on coronary artery calcium (CAC) scores of 100 Agatston Units or demographic-specific 75th percentile thresholds.
  • Existing data informing CAC percentiles for adults aged 75-85 years are limited, with scarce information for individuals aged 85 and older.
  • There is a need for updated, population-specific CAC distributions and percentiles in older adults to accurately guide ASCVD risk assessment.

Purpose of the Study:

  • To characterize the distribution of coronary artery calcium (CAC) in adults aged 75 years and older.
  • To establish demographic-specific (sex and race) CAC percentiles for individuals aged 75 years and older.
  • To provide updated data for interpreting CAC scores in the geriatric population for ASCVD risk stratification.

Main Methods:

  • Analysis of 2886 participants aged ≥75 years without clinical coronary heart disease from the ARIC and MESA studies.
  • Estimation of CAC prevalence (>0) and sex- and race-specific CAC percentiles using nonparametric locally weighted regression and pooled residual ranking.
  • Inclusion of data from ARIC visit 7 (2018-2019) and MESA visit 5 (2010-2011).

Main Results:

  • The prevalence of zero CAC was 11% in community-dwelling adults aged ≥75 years.
  • Regardless of sex and race, 62.5% of participants had CAC >100 Agatston Units, suggesting most older adults would be classified as high risk under current thresholds.
  • CAC scores increased with age, with approximately 95% of participants aged ≥90 years having detectable CAC across subgroups.
  • The 75th percentile CAC scores were higher for Black older adults, particularly females, compared to existing thresholds.

Conclusions:

  • In adults aged ≥75 years free of clinical coronary heart disease, a CAC score >100 Agatston Units would classify the majority as high risk for ASCVD.
  • Demographic-specific CAC percentiles derived from this study are crucial for accurate CAC interpretation in the ≥75 years population.
  • Updated CAC percentiles are essential for refining ASCVD risk assessment and preventive therapy decisions in older adults.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
39
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12